| Patent | Date |
|---|
Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents
App 20060128655 - Falk; Rudolf Edgar ; et al. | 2006-06-15 |
Use of hyaluronic acid and forms to prevent the narrowing of the vascular walls
Grant 6,852,708 - Falk , et al. February 8, 2 | 2005-02-08 |
Treatment of conitions and disease
App 20040019011 - Falk, Rudolf Edgar ; et al. | 2004-01-29 |
Treatment of conditions and disease
Grant 6,194,392 - Falk , et al. February 27, 2 | 2001-02-27 |
Formulations containing hyaluronic acid
Grant 6,114,314 - Falk , et al. September 5, 2 | 2000-09-05 |
Therapeutic methods using hyaluronic acid
Grant 6,103,704 - Falk , et al. August 15, 2 | 2000-08-15 |
Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents
Grant 6,069,135 - Falk , et al. May 30, 2 | 2000-05-30 |
Treatment of conditions and disease
Grant 6,048,844 - Falk , et al. April 11, 2 | 2000-04-11 |
Use of hyaluronic acid and forms to prevent arterial restenosis
Grant 6,022,866 - Falk , et al. February 8, 2 | 2000-02-08 |
Topical composition containing hyaluronic acid and nsaids
Grant 6,017,900 - Falk , et al. January 25, 2 | 2000-01-25 |
Use of hyaluronic acid and forms to prevent arterial restenosis
Grant 5,990,095 - Falk , et al. November 23, 1 | 1999-11-23 |
Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
Grant 5,985,851 - Falk , et al. November 16, 1 | 1999-11-16 |
Compositions comprising hyaluronic acid and drugs
Grant 5,985,850 - Falk , et al. November 16, 1 | 1999-11-16 |
Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
Grant 5,972,906 - Asculai , et al. October 26, 1 | 1999-10-26 |
Topical composition containing hyaluronic acid and NSAIDS
Grant 5,962,433 - Falk , et al. October 5, 1 | 1999-10-05 |
Treatment of conditions and disease
Grant 5,932,560 - Falk , et al. August 3, 1 | 1999-08-03 |
Treatment of conditions and disease
Grant 5,929,048 - Falk , et al. July 27, 1 | 1999-07-27 |
Treatment of disease and conditions
Grant 5,914,322 - Falk , et al. June 22, 1 | 1999-06-22 |
Use of a form of hyaluronic acid and a medicinal agent for reducing rejection of organs transplantation in mammals
Grant 5,914,314 - Falk , et al. June 22, 1 | 1999-06-22 |
Topical composition containing hyaluronic acid and NSAIDS
Grant 5,910,489 - Falk , et al. June 8, 1 | 1999-06-08 |
Treatment of conditions and disease
Grant 5,852,002 - Falk , et al. December 22, 1 | 1998-12-22 |
Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID
Grant 5,847,002 - Willoughby , et al. December 8, 1 | 1998-12-08 |
Hyaluronic acid and salts thereof inhibit arterial restenosis
Grant 5,834,444 - Falk , et al. November 10, 1 | 1998-11-10 |
Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
Grant 5,830,882 - Falk , et al. November 3, 1 | 1998-11-03 |
Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
Grant 5,827,834 - Falk , et al. October 27, 1 | 1998-10-27 |
Topical composition containing hyaluronic acid and NSAIDS
Grant 5,824,658 - Falk , et al. October 20, 1 | 1998-10-20 |
Clearing of atherosclerosis
Grant 5,817,642 - Falk , et al. October 6, 1 | 1998-10-06 |
Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
Grant 5,811,410 - Falk , et al. September 22, 1 | 1998-09-22 |
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
Grant 5,792,753 - Falk , et al. August 11, 1 | 1998-08-11 |
Use of hyaluronic acid to repair ischemia reperfusion damage
Grant 5,674,857 - Falk , et al. October 7, 1 | 1997-10-07 |
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
Grant 5,639,738 - Falk , et al. June 17, 1 | 1997-06-17 |
| 